Larimar Therapeutics
LRMR
LRMR
48 hedge funds and large institutions have $160M invested in Larimar Therapeutics in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
19% less funds holding
Funds holding: 59 → 48 (-11)
69% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 16
Holders
48
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$2.25M | |
| 2 | +$594K | |
| 3 | +$573K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$544K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$483K |
Top Sellers
| 1 | -$2.77M | |
| 2 | -$1.66M | |
| 3 | -$1.02M | |
| 4 |
6CM
683 Capital Management
New York
|
-$689K |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$426K |